Antimicrobial Resistance in Relation to Virulence Determinants and Phylogenetic Background Among Uropathogenic Escherichia coli in Lebanon

REFERENCES

• Russo TA, Johnson JR. A proposal for an inclusive desig-nation for extraintestinal pathogenic Escherichia coil: ExPEC. J Infect Dis 2000; 181: 1753:1754.
   Google Scholar
• Orskov F, Orskov I. Escherichia coil serotyping and dis-ease in man and animals. Can J Microbiol 1992; 38: 699–704.
   PubMed Web of Science ®Google Scholar
• Bingen-Bidois M, Clermont O, Bonacorsi M, Terki M, Brahimi N, Loukil D, et al. Phylogenetic analysis and prevalence of urosepsis strains of Escherichia coil bearing pathogenecity is-land-like domains. Infect Immun 2002; 70: 3216–3226.
   PubMed Web of Science ®Google Scholar
• Raksha R, Srinivasa H, Macaden RS. Occurence and char-acterization of uropathogenic Escherichia coil in urinary tract infections. Indian J Med Microbiol 2003; 21 (2): 102–107.
   PubMedGoogle Scholar
• Karlowsky JA, Jones ME, Thornsberry C, Critchley I, Kelly LJ, Sahm DF. Prevalence of antimicrobial resistance among uri-nary tract pathogens isolated from female outpatients across the US in 1999. Int J Antimicrob Agents 2001; 18: 121–127.
   PubMed Web of Science ®Google Scholar
• Nicolle LE. Urinary tract pathogens in complicated infection and in elderly individuals. J Infect Dis 2001; 183 (Suppl 1): S5–S8.
   PubMedGoogle Scholar
• Drews SJ, Poutanen SM, Mazzulli T, McGeer AJ, Sarabia A, Pong-Porter S. Decreased prevalence of virulence factors among ciprofloxacin- resistant uropathogenic Escherichia coil isolates. J Clin Microbiol 2005 ; 43 (8): 4218–4220.
   PubMed Web of Science ®Google Scholar
• Naber KG, Roscher K, Sotto H, Schaefer V. Oral Lev-ofloxacin 500 mg once daily in the treatment of chronic bacterial prostatitis. Int J Antimirob Agents 2008 ; 32 : 145–153.
   PubMed Web of Science ®Google Scholar
• Haugen BJ, Pellett S, Redford P, Hamilton HL, Roesch PL, Welch RA. In vivo expression analysis identifies genes required for enhanced colonization of the mouse urinary tract by uropathogenic Escherichia coil strain CFT073 dsdA. Infect Immun 2007; 75 (1): 278–289.
   PubMed Web of Science ®Google Scholar
• Henderson IR, Czeczulin J, Eslava C, Noriega F, Nataro JP. Characterization of pic, a secreted protease of Shigella flexneri and enteroaggregative Escherichia coil. Infect Immun 1999; 67: 5587–5596.
   PubMed Web of Science ®Google Scholar
• Guyer DM, Radulovie S, Jones FE, Mobley HLT. Sat, the secreted autotransporter toxin of uropathogenic Escherichia coil, is a vacuolating cytotoxin for bladder and kidney epithelial cells. Infect Immun 2002; 70 (8): 4539–4546.
   PubMed Web of Science ®Google Scholar
• Henderson IR, Nataro J. Virulence functions of auto-transporter proteins. Infect Immun 2001; 69 (3): 1231–1243.
   PubMed Web of Science ®Google Scholar
• Parham NJ, Pollard SJ, Chaudhuri RR, Beatson SA, Desvaux M, Russell MA, et al. Prevalence of pathogenicity island IICFT073 genes among extraintestinal clinical isolates of Es-cherichia coil. J Clin Microbiol 2005; 43 (5): 2425–2434.
   PubMed Web of Science ®Google Scholar
• Xie J, Foxman B, Zhang L, Marrs CF. Molecular epi-demiologic identification of Escherichia coil genes that are po-tentially involved in movement of the organism from the intestinal tract to the vagina and bladder. J Clin Microbiol 2006; 44 (7): 2434–2441.
   PubMed Web of Science ®Google Scholar
• Johnson JR, Kuskowski MA, Gajewski A, Sahm DF, Kar-lowsky JA. Virulence characteristics and phylogenetic back-ground of multidrug-resistant and antimicrobial-susceptible clinical isolates of Escherichia coil from across the United States, 2000-2001. J Infect Dis 2004; 190: 1739–1744.
   PubMed Web of Science ®Google Scholar
• Lloyd AL, Rasko DA, Mobley HLT. Defining genomic is-lands and uropathogenic-specific genes in uropathogenic Es-cherichia coil. J Bacteriol 2007; 189: 3532–3546.
   PubMed Web of Science ®Google Scholar
• Schaeffer AJ, Rajan N, Cao Q, Anderson BE, Pruden DL, Sensibar J, et al. Host pathogenesis in urinary tract infections. Int J Antimicrob Agents 2001; 17: 245–251.
   PubMed Web of Science ®Google Scholar
• Goullet P, Picard B. Electrophoretic type B2 of car-boxylesterase B for characterization of highly pathogenic Es-cherichia coil strains from extra-intestinal infections. J Gen Microbiol 1990; 33: 1–6.
   Google Scholar
• Lecointre G, Rachdi L, Darlu P, Denamur E. Echerichia coil molecular phylogeny using the incongruence length differ-ence test. Mol Biol Evol 1998; 15 (12): 1685–1695.
   PubMed Web of Science ®Google Scholar
• Picard B, Garcia JS, Gouriou S, Duriez P, Brahimi N, Bin-gen E, et al. The link between phylogeny and virulence in Es-cherichia coil extraintestinal infection. Infect Immun 1999; 67: 546–553.
   PubMed Web of Science ®Google Scholar
• Duriez P, Clermont O, Bonacorsi S, Bingen E, Chaventre A, Elion J, et al. Commensal Escherichia coil isolates are phy-logenetically distributed among geographically distinct human populations. Microbiology 2001; 147: 1671–1676.
   PubMed Web of Science ®Google Scholar
• Zhang L, Foxman B, Marrs C. Both urinary and rectal Es-cherichia coil isolates are dominated by strains of phylogentic group B2. J Clin Microbiol 2002; 40 (11): 3951–3955.
   PubMed Web of Science ®Google Scholar
• Chen FJ, McDonald LC, Ho M, Lo HJ. Identification of reduced fluoroquinolone susceptibility in Escherichia coil: A herald for emerging resistance. J Antimicrob Chemother 2001; 48: 936–938.
   PubMed Web of Science ®Google Scholar
• Delong E. Archaea in coastal marine environments. PNAS 1992; 89: 5685–5689.
   PubMed Web of Science ®Google Scholar
• Suzuki M, Giovannoni S. Bias caused by template an-nealing in the amplification mixtures of 16S rRNA genes by PCR. Appl Environ Microbiol 1996; 62: 625–630.
   PubMed Web of Science ®Google Scholar
• Clermont O, Bonacorsi S, Bingen E. Rapid and simple de-termination of the Escherichia coil phylogenetic group. Appl En-viron Microbiol 2000; 66 (10): 4555–4558.
   PubMed Web of Science ®Google Scholar
• National Committee for Clinical Laboratory Standards. Approved standard M2-A9. Performance standards for antimi-crobial susceptibility testing. 9th ed. National Committee for Clin-ical Laboratory Standards, Wayne, PA; 2006.
   Google Scholar
• Johnson JR, Kuskowski MA, O'Bryan TT, Colodner R, Raz R. Virulence genotype and phylogenetic origin in relation to antibiotic resistance profile among Escherichia coil urine sample isolates from Israeli Women with acute uncomplicated cystitis. Antimicrob Agents Chemother 2005; 49 (1): 26–31.
   PubMed Web of Science ®Google Scholar
• Rasko DA, Phillips JA, Li X, Mobley HL. Identification of DNA sequences from a second pathogenicity island of uropath-ogenic Escherichia coil CFT073: probes specific for uropatho-genic populations. J Infect Dis 2001; 184: 1041–1049.
   PubMed Web of Science ®Google Scholar
• Heimer SR, Rasko DA, Lockatell, CV, Johnson DE, Mob-ley HL. Autotransporter genes plc and tsh are associated with Escherichia coil strains that cause acute pyelonephritis and are expressed during urinary tract infection. Infect Immun 2004; 72: 593–597.
   PubMed Web of Science ®Google Scholar
• Kiffer CR, Mendes C, Oplustil CP, Sampaio JL. Antibiotic resistance and trend of urinary pathogens in general outpatients from a major urban city. Int Braz J Urol 2007; 33: 42–49.
   PubMedGoogle Scholar
• Warren JV, Abrutyn E, Hebei R, Johnson JR, Schaeffer AJ, Stamm WE. Guidelines for the treatment of uncomplicated acute baterial cystitis and acute pyelonephritis in women. Clin In-fect Dis 1999; 29: 745–758.
   PubMed Web of Science ®Google Scholar
• Cagnacci S, Gualco L, Debbia E, Schito G, Marchese A. European Emergence of ciprofloxacin-resistant Escherichia coil clonal groups 025:H4-ST 131 and 015:K52:H1 causing community-acquired uncomplicated cystitis. J Clin Microbiol 2008; 46: 2605–2612.
   PubMed Web of Science ®Google Scholar
• Johnson JR, Van der Schee C, Kuskowski MA, Goessens W, Van Belkum A. Phylogenetic background and virulence profiles of fluoroquinolone-resistant clinical Escherichia coil isolates from the Netherlands. J Infect Dis 2002; 186: 1852–1856.
   PubMed Web of Science ®Google Scholar
• Moreno E, Prats G, Sabate M, Perez T, Johnson JR, An-dreu A. Quinolone, fluoroquinolone and trimethoprim/sul-famethoxazole resistance in relation to virulence determinants and phylogenetic background among pathogenic Escherichia coil. J Antimicrob Chemother 2006; 57: 204–211.
   PubMed Web of Science ®Google Scholar
• Johnson JR, Johnston B, Kuskowski MA, Colodner R, Raz R. Spontaneous conversion to quinolone and fluoro-quinolone resistance among wild-type Escherichia coil isolates in relation to phylogenetic background and virulence genotype. Antimicrob Agents Chemother 2005; 49 (11): 4739–4744.
   PubMed Web of Science ®Google Scholar